论文部分内容阅读
为了全面地了解我国梅毒发生、发展和分布的特点及流行的规律，为制订控制梅毒的对策提供科学依据，我们于１９９０～１９９４年对全国３８个城市监测点用统一的方法、步骤和表格作了连续五年的梅毒发病情况的调查。总计发现梅毒病例５０７８例，占ＳＴＤ构成比为１．３４％，平均年发病率为０．９４／１０万，平均年增长率为２３．０６％，男性平均年发病率为１．０９／１０万，女性平均年发病率为０．７５／１０万。我国目前流行的主要是早期梅毒，占９４．７０％，其中一期梅毒２０．１６％，二期梅毒４６．５１％，早期隐性梅毒２８．１０％；此外，三期梅毒为２．１０％，先天梅毒为０．７０％。以２０～２９岁和３０～３９岁年龄组发病率最高，分别为１．８０／１０万和１．５６／１０万。从职业分析以个体者、待业者、驾驶员发病率为最高。我国梅毒发病率较高的地区，北方是新疆、陕西、甘肃和天津，南方是福州、桂林、杭州、南宁和海口一些旅游城市，尤其是南方城市近年来呈明显上升之趋势。作者认为：必须继续进行对我国梅毒流行的监测，加强提高梅毒诊断技术和治疗方法，加强长效青霉素制剂的生产和供应，以保证梅毒防治工作的开展。
In order to comprehensively understand the characteristics of the occurrence, development and distribution of syphilis in China, and to provide a scientific basis for formulating countermeasures for the control of syphilis, we used uniform methods, procedures, and forms for monitoring sites in 38 cities across the country from 1990 to 1994. The investigation of the incidence of syphilis for five consecutive years. A total of 5,078 cases of syphilis were found, accounting for 1.34% of the STD, with an average annual incidence of 0.94 per 100,000, an average annual growth rate of 23.06%, and an average annual incidence of 1.09/10 men. The average annual incidence of women is 0.75 per 100,000. China’s current prevalence is mainly early syphilis, accounting for 94.70%, of which a period of syphilis is 20.16%, secondary syphilis is 46.51%, early recessive syphilis is 28.10%; in addition, tertiary syphilis is 2.10 %, congenital syphilis is 0.70%. The incidence rates of the 20 to 29 and 30 to 39 age groups were the highest, 1.80/100,000 and 1.56/lakh respectively. The incidence rate of the individual, the unemployed, and the driver from the job analysis is the highest. The regions with high incidence of syphilis in China are Xinjiang, Shaanxi, Gansu, and Tianjin in the north, and some tourist cities in Fuzhou, Guilin, Hangzhou, Nanning, and Haikou in the south. In particular, southern cities have seen a clear upward trend in recent years. The author believes that: we must continue to monitor the epidemic of syphilis in China, strengthen the diagnosis and treatment of syphilis, and strengthen the production and supply of long-acting penicillin preparations to ensure the development of syphilis control.